ByTrending Posts
ImmunAI and Teva Partner to Enhance Clinical Trials…
New York, NY – Nov 14, 2024 Strategic Collaboration Aims to Improve Drug Development Efficiency and Patient Outcomes:ImmunAI,…
Medable and Google Cloud Partner to Advance AI-Powered…
PALO ALTO, Calif. – October 30, 2024 Strategic Collaboration to Accelerate Clinical Research Medable Inc., a leader in…
Odyssey and Terray Forge AI-Powered Partnership to Advance…
Boston and Los Angeles – Oct 28, 2024 With Odyssey’s established track record in immunology and Terray’s cutting-edge…
Dyno Therapeutics and Roche Expand Strategic Partnership for…
October 24, 2024 Dyno Therapeutics has expanded its collaboration with Roche to advance next-generation adeno-associated virus (AAV) vectors…
Six Ways Johnson & Johnson is Leveraging AI…
October 10, 2024 Johnson & Johnson is at the forefront of integrating Artificial Intelligence (AI) to drive healthcare…
BullFrog AI Publishes Data Highlighting Potential of BF-114…
Gaithersburg, Md – Oct 9 2024 BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW), a technology-enabled drug development company…
ProJenX and Unlearn AI Collaborate to Advance AI-Powered…
San Francisco – September 27, 2024 ProJenX, a clinical-stage biotech company, has partnered with Unlearn AI to enhance…
Novartis and Generate:Biomedicines Announce Strategic AI-Driven Protein Therapeutics…
Somerville, MA — Sept 24, 2024 Combining AI innovation with pharma expertise to accelerate drug development and tackle…
Eli Lilly and Genetic Leap Forge $409M Strategic…
New York – Sept 24 2024 Eli Lilly and Company (NYSE: LLY) has entered into a landmark $409…
Trending Posts
Latest Stories
Will the US Health Agency Expand Coverage for GLP-1 Weight-Loss Drugs?
The U.S. Centers for Medicare & Medicaid Services (CMS) announced a new voluntary program to…
How is Bristol Myers Squibb Driving Growth After 2025’s Strategic Recalibration?
Bristol Myers Squibb (BMS) continues to build momentum in its post-loss-of-exclusivity strategy, with 2025 marked…
Will Agios Pharma’s FDA Approval Expansion Drive a New Growth Phase in Blood Disorder Treatment?
Cambridge, Massachusetts | December 26, 2025 Agios Pharmaceuticals announced a major regulatory milestone after the…
Novartis Builds on a Track Record of Expansion Ahead of the 2026 J.P. Morgan Healthcare Conference
Basel, Switzerland Novartis closed 2025 with sustained operational momentum, building on its transformation into a…
Gallery
